| Active substance |
Sildenafil Citrate |
| Also known as |
Plavix, Iscover |
| Blood pressure |
No direct effect |
| Chemical name |
Methyl (+)-(S)-О±-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate sulfate (1:1) |
| Dosage (medical) |
75 mg once daily |
| Dosage (sports) |
Not applicable |
| Effects |
Reduces the risk of stroke, myocardial infarction, and vascular death in patients with atherosclerosis |
| Formula |
C16H16ClNO2SВ·H2SO4 |
| Half-life |
Approximately 6 hours |
| Hepatotoxicity |
Rare, but possible liver function disturbances |
| Lab Test |
Monitoring not typically required, but platelet function tests can be affected |
| Main action |
Inhibits platelet aggregation |
| Side effects |
Bleeding, bruising, gastrointestinal discomfort, thrombotic thrombocytopenic purpura |
| Storage conditions |
Store at 20-25В°C (68-77В°F) |
| Strength |
75mg |
| Substance class |
Thienopyridine antiplatelet agent |
| Trade name |
Plavix |
| Use in sports |
Not typically used in sports |
| Water Retention |
No significant effect |
| Manufacturer |
Rescuers Life Sciences Ltd. |
| Packing |
10 tabs/blister |
